Recent Developments in Medical Technology Boost Cosmetic Implants Market

Cosmetic implants are being increasingly used across the globe to enhance the physical functioning or aesthetic appearance of different parts of the body. Rise in incomes and healthcare expenditure, increasing number of cosmetic surgeons and surgeries, advent of advanced surgical and medical device technology, and growing medical infrastructure are some of the key factors driving the demand for cosmetic implants.

In 2013, the global cosmetic implants market was estimated to be worth US$2.1 billion, according to a report by Transparency Market Research. This is projected to rise to US$3.2 billion by 2020, growing at a moderate CAGR of 5.7% from 2014 to 2020.

Here are some of the top developments in the field of cosmetic implants.

Browse Market Research Report of Cosmetic Implants Market: http://www.transparencymarketresearch.com/cosmetic-implants-market.html

Swiss-made Metal-free Zirconia Dental Implants Receive FDA Approval

The US Food and Drug Administration (FDA) has recently approved Zirkolith dental implants, which are being termed the world’s first two-piece and tapered all-zirconia dental implant. Approved by the FDA this month for use in the US, Zirkolith is developed by Swiss-based Z-Systems, which provides leading solutions for naturally white, metal-free zirconia dental implants. While most dental implants are still made of titanium, Zirkolith implants are made from the highest quality zirconia, which has been used in medical devices for hip replacements since the 1980s.

While the Z5c two-piece zirconia implant offers similar benefits as the titanium tapered implants, it is free from a grey shine. The implants also provide high primary stability in situations of poor bone quality. Zirkolith overcomes all aesthetic limitations and offers excellent reliability and osseointegration together with highest biocompatibility. 

3D-Printed Facial Implants Emerge as Alternative Method to Correct Facial Positioning 

Dr. Mohd Nazimi Abd Jabar of the Universiti Kebangsaan Malaysia (UKM) has developed a 3D printed facial implant that can be used to treat accident victims with severe facial injuries and defects. Last month, Dr Mohd Nazimi, a maxillofacial surgery expert, reconstructed a patient’s skull around her left eye, using a 3D planning software and a custom-made 3D-printed titanium device. The 3D-printed implant not only lent remarkable support to the patient’s eye socket and restored the anatomy, but also mimicked the properties of the real bone. 

Compared to traditional facial implants, 3D-printed implants retain optimal strength in addition to being lightweight and porous. This has proved to be more comfortable for the patient. 

Browse Market Research Press Release of Cosmetic Implants Market: http://www.transparencymarketresearch.com/pressrelease/cosmetic-implants-market.htm

Robot-Assisted Surgeries Boosting Demand for Implants used in Hip, Knee Replacement

Dr Michael Ast, medical director of Robert Wood Johnson University Hospital’s Robotic Joint Replacement Program, said last month that more than 1 million knee and hip surgeries are being performed by US doctors annually, and this is greatly driven by the introduction of robot- or computer-assisted technologies. Before robotic assistance became available, inserting and placing an implant in the most precise position was increasingly difficult. In the event that the implant wasn’t put in well, the chances of it failing rapidly rose to a larger extent. 

The MAKOplasty, a US$1 million robotic device acquired by Monmouth Medical Center in New Jersey, is the size of a desk and with its various adaptors, is ideal for candidates for hip and knee replacements. Robotic or computer-assisted surgeries improve the stability of the patient, optimize leg strength, and minimize the chances of implant dislocation. 

Companies that have a strong presence in the global cosmetic implants market include GC Aesthetics, Spectrun Designs Medical, 3M Health Care, Mentor Worldwide LLC., Allergan Inc., Zimmer Holdings Inc., Institut Straumann AG, and Nobel Biocare Holding AG.